Physician profile
Ashish Singh
NPI 1669859328
$4,943.34
in general payments reported to CMS, 2019-2025
14 companies · $784 in 2025
The $784 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $898 · 2020: $35.69 · 2021: $265 · 2022: $558 · 2023: $436 · 2024: $1,966 · 2025: $784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,438 · Travel and Lodging: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,437.76 |
| Travel and Lodging | $748.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,471.51 | 2019-2025 | Lensx, Clareon, Ngenuity |
| Glaukos Corporation | $800.56 | 2019-2025 | Istent Trabecular Micro-Bypass System Model Is3, Idosetr |
| Biotissue Holdings INC. | $550.99 | 2021-2025 | |
| Rxsight INC | $357.83 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Lensar, INC. | $189.79 | 2025 | Lensar Laser System |
| Bausch & Lomb Americas INC. | $147.59 | 2022-2023 | Envista Mx60 Iol, Ic-8 Apthera Iol |
| Johnson & Johnson Surgical Vision, INC. | $111.48 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $108.19 | 2021 | |
| Sight Sciences, INC. | $48.00 | 2019-2022 | |
| Abbvie INC. | $47.22 | 2023-2024 | Alphagan P, Vuity, Lumigan |
| Allergan, INC. | $45.37 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.33 | 2022 | |
| Sun Pharmaceutical Industries INC. | $18.30 | 2021 | |
| Oyster Point Pharma, INC. | $15.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.